04:12 AM EDT, 05/12/2026 (MT Newswires) -- Coloplast (COLO-B.CO) confirmed its financial guidance for its organic revenue growth for 2026.

The Danish medical device company expects organic revenue to increase 5% to 6% in the full year, according to a Tuesday release.

The reported revenue growth in Danish kroner is expected to be around 3% due to the negative currency impact.

Ämnen i artikeln

Coloplast B

Senast

404,00

1 dag %

0,10%

1 dag

1 mån

1 år

Marknadsöversikt

1 DAG %

Senast

1 mån